Cancer Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Cancer Vaccines Market: by Vaccine Type (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector & DNA Cancer Vaccines) Indication (Prostate Cancer, Cervical Cancer, Others) Application (Preventive Vaccine, Therapeutic Vaccine) and Geograpy

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

1. Executive Summary
2. Global Cancer Vaccines Market Introduction
2.1. Global Cancer Vaccines Market – Taxonomy
2.2. Global Cancer Vaccines Market –Definitions
2.2.1. Vaccine Type
2.2.2. Indication
2.2.3. Application
2.2.4. Region
3. Global Cancer Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Current Trends
3.5. Global Cancer Vaccines Market Dynamic Factors – Impact Analysis
3.6. Mergers, Acquisitions, and Collaborations
4. Global Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cancer Vaccines Market, By Vaccine Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Dendritic Cells (DC) Cancer Vaccines
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Recombinant Cancer Vaccines
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antigen/Adjuvant Cancer Vaccines
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Viral Vector & DNA Cancer Vaccines
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Cancer Vaccines Market, By Indication, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. Prostate Cancer
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Cervical Cancer
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Cancer Vaccines Market, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. Preventive Vaccine
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Therapeutic Vaccine
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Cancer Vaccines Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. MEA
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, and Country, 2022 – 2028
9. North America Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Dendritic Cells (DC) Cancer Vaccines
9.1.2. Recombinant Cancer Vaccines
9.1.3. Antigen/Adjuvant Cancer Vaccines
9.1.4. Viral Vector & DNA Cancer Vaccines
9.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Prostate Cancer
9.2.2. Cervical Cancer
9.2.3. Others
9.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Preventive Vaccine
9.3.2. Therapeutic Vaccine
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.4.1. United States
9.4.2. Canada
9.5. North America Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
9.6. North America Cancer Vaccines Market Dynamics – Trends
10. Europe Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Dendritic Cells (DC) Cancer Vaccines
10.1.2. Recombinant Cancer Vaccines
10.1.3. Antigen/Adjuvant Cancer Vaccines
10.1.4. Viral Vector & DNA Cancer Vaccines
10.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Prostate Cancer
10.2.2. Cervical Cancer
10.2.3. Others
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Preventive Vaccine
10.3.2. Therapeutic Vaccine
10.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. UK
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
10.6. Europe Cancer Vaccines Market Dynamics – Trends
11. Asia Pacific Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Dendritic Cells (DC) Cancer Vaccines
11.1.2. Recombinant Cancer Vaccines
11.1.3. Antigen/Adjuvant Cancer Vaccines
11.1.4. Viral Vector & DNA Cancer Vaccines
11.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Prostate Cancer
11.2.2. Cervical Cancer
11.2.3. Others
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Preventive Vaccine
11.3.2. Therapeutic Vaccine
11.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. ANZ
11.4.4. Japan
11.4.5. Rest of APAC
11.5. Asia Pacific Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
11.6. Asia Pacific Cancer Vaccines Market Dynamics – Trends
12. MEA Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Dendritic Cells (DC) Cancer Vaccines
12.1.2. Recombinant Cancer Vaccines
12.1.3. Antigen/Adjuvant Cancer Vaccines
12.1.4. Viral Vector & DNA Cancer Vaccines
12.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Prostate Cancer
12.2.2. Cervical Cancer
12.2.3. Others
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Preventive Vaccine
12.3.2. Therapeutic Vaccine
12.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of MEA
12.5. MEA Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
12.6. MEA Cancer Vaccines Market Dynamics – Trends
13. Latin America Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Dendritic Cells (DC) Cancer Vaccines
13.1.2. Recombinant Cancer Vaccines
13.1.3. Antigen/Adjuvant Cancer Vaccines
13.1.4. Viral Vector & DNA Cancer Vaccines
13.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Prostate Cancer
13.2.2. Cervical Cancer
13.2.3. Others
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Preventive Vaccine
13.3.2. Therapeutic Vaccine
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Argentina
13.4.4. Rest of LA
13.5. Latin America Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
13.6. Latin America Cancer Vaccines Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Anixa Biosciences Inc.
14.2.2. Dynavax Technologies Corporation
14.2.3. Vaccinogen, Inc.
14.2.4. Astrazeneca plc
14.2.5. Moderna Inc.
14.2.6. Vaccitech Limited
14.2.7. F Hoffmann-La Roche AG
14.2.8. GlaxoSmithKline PLC
14.2.9. Sanofi SA
14.2.10. Dendreon Pharmaceuticals LLC
15. Research Methodology
16. Key Assumptions and Acronyms

 

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Anixa Biosciences Inc.
  • Dynavax Technologies Corporation
  • Vaccinogen, Inc.
  • Astrazeneca plc
  • Moderna Inc.
  • Vaccitech Limited
  • F Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Sanofi SA
  • Dendreon Pharmaceuticals LLC

Description

1. Executive Summary
2. Global Cancer Vaccines Market Introduction
2.1. Global Cancer Vaccines Market – Taxonomy
2.2. Global Cancer Vaccines Market –Definitions
2.2.1. Vaccine Type
2.2.2. Indication
2.2.3. Application
2.2.4. Region
3. Global Cancer Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Current Trends
3.5. Global Cancer Vaccines Market Dynamic Factors – Impact Analysis
3.6. Mergers, Acquisitions, and Collaborations
4. Global Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cancer Vaccines Market, By Vaccine Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Dendritic Cells (DC) Cancer Vaccines
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Recombinant Cancer Vaccines
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antigen/Adjuvant Cancer Vaccines
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Viral Vector & DNA Cancer Vaccines
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Cancer Vaccines Market, By Indication, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. Prostate Cancer
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Cervical Cancer
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Cancer Vaccines Market, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. Preventive Vaccine
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Therapeutic Vaccine
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Cancer Vaccines Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. MEA
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, and Country, 2022 – 2028
9. North America Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Dendritic Cells (DC) Cancer Vaccines
9.1.2. Recombinant Cancer Vaccines
9.1.3. Antigen/Adjuvant Cancer Vaccines
9.1.4. Viral Vector & DNA Cancer Vaccines
9.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Prostate Cancer
9.2.2. Cervical Cancer
9.2.3. Others
9.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Preventive Vaccine
9.3.2. Therapeutic Vaccine
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.4.1. United States
9.4.2. Canada
9.5. North America Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
9.6. North America Cancer Vaccines Market Dynamics – Trends
10. Europe Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Dendritic Cells (DC) Cancer Vaccines
10.1.2. Recombinant Cancer Vaccines
10.1.3. Antigen/Adjuvant Cancer Vaccines
10.1.4. Viral Vector & DNA Cancer Vaccines
10.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Prostate Cancer
10.2.2. Cervical Cancer
10.2.3. Others
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Preventive Vaccine
10.3.2. Therapeutic Vaccine
10.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. UK
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
10.6. Europe Cancer Vaccines Market Dynamics – Trends
11. Asia Pacific Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Dendritic Cells (DC) Cancer Vaccines
11.1.2. Recombinant Cancer Vaccines
11.1.3. Antigen/Adjuvant Cancer Vaccines
11.1.4. Viral Vector & DNA Cancer Vaccines
11.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Prostate Cancer
11.2.2. Cervical Cancer
11.2.3. Others
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Preventive Vaccine
11.3.2. Therapeutic Vaccine
11.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. ANZ
11.4.4. Japan
11.4.5. Rest of APAC
11.5. Asia Pacific Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
11.6. Asia Pacific Cancer Vaccines Market Dynamics – Trends
12. MEA Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Dendritic Cells (DC) Cancer Vaccines
12.1.2. Recombinant Cancer Vaccines
12.1.3. Antigen/Adjuvant Cancer Vaccines
12.1.4. Viral Vector & DNA Cancer Vaccines
12.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Prostate Cancer
12.2.2. Cervical Cancer
12.2.3. Others
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Preventive Vaccine
12.3.2. Therapeutic Vaccine
12.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of MEA
12.5. MEA Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
12.6. MEA Cancer Vaccines Market Dynamics – Trends
13. Latin America Cancer Vaccines Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Vaccine Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Dendritic Cells (DC) Cancer Vaccines
13.1.2. Recombinant Cancer Vaccines
13.1.3. Antigen/Adjuvant Cancer Vaccines
13.1.4. Viral Vector & DNA Cancer Vaccines
13.2. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Prostate Cancer
13.2.2. Cervical Cancer
13.2.3. Others
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Preventive Vaccine
13.3.2. Therapeutic Vaccine
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Argentina
13.4.4. Rest of LA
13.5. Latin America Cancer Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Indication, Application, 2016-2027
13.6. Latin America Cancer Vaccines Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Anixa Biosciences Inc.
14.2.2. Dynavax Technologies Corporation
14.2.3. Vaccinogen, Inc.
14.2.4. Astrazeneca plc
14.2.5. Moderna Inc.
14.2.6. Vaccitech Limited
14.2.7. F Hoffmann-La Roche AG
14.2.8. GlaxoSmithKline PLC
14.2.9. Sanofi SA
14.2.10. Dendreon Pharmaceuticals LLC
15. Research Methodology
16. Key Assumptions and Acronyms

 

Reviews

There are no reviews yet.

Be the first to review “Cancer Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX